IGBA Kicks Off Biosimilars Week With New White Paper

Urges Regulators To Adopt Principles Of Revised WHO Biosimilars Guideline

The IGBA has kicked off its third annual global biosimilars week awareness campaign with the release of a white paper that urges stakeholders to recognize and adopt recommendations from the WHO’s latest revised biosimilars guideline.

World Map Syringe Vial
The IGBA’s third annual global biosimilars week runs from 14-18 November • Source: Shutterstock

A third global biosimilars week awareness campaign running from 14-18 November has been launched by the International Generic and Biosimilar Medicines Association, with the IGBA also taking this opportunity to launch a new white paper that urges the uptake of recommendations from the World Health Organization’s latest revised biosimilars guideline from earlier this year.

“In the week ahead, IGBA will renew its commitment to the collaborative effort to establish worldwide biosimilar policies that deliver...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.